Psoriatic Arthritis Market, By Drug Class (DMARD, NSAIDs, Biologics, and Others), By Product Type (OTC and Prescriptions), By Route of Administration (Oral, Topical, and Injectable), and By Region - Trends, Analysis, and Forecast till 2029

The regions that make up the global market for psoriatic arthritis include Latin America, North America, Europe, Asia Pacific, the Middle East, and Africa. The commercial sales of products in the United States, North America, and Europe together control the majority of the global market for psoriatic arthritis. The existence of major manufacturers, proactive government initiatives, advantageous reimbursement systems, and a sizable patient base further support the expansion of the psoriatic arthritis treatment market. Additionally, the market is anticipated to expand quickly in the Asia Pacific region due to the region's general economic growth, upgraded healthcare facilities, rising disposable income, and increased consumer awareness.